GILD logo

Gilead Sciences, Inc.

GILD
0.00
USD
+0.00+0.00%

Gilead Sciences, Inc. at a glance

Open GILD on Vela

Gilead Sciences, Inc. (GILD) is a Healthcare company in the Drug Manufacturers - General industry, headquartered in Foster City, CA, with about 17,000 employees. Its shares trade on NASDAQ, and its IPO date is January 22, 1992. With a market capitalization of $193.5 billion, GILD is a large-cap stock.

It trades an average of 6.6 million shares a day.

In its latest reported quarter (results released August 4, 2026), Gilead Sciences, Inc. posted revenue of $7.8 billion and earnings of -$6.75 per share, against estimates of $7.4 billion and -$7.25.

Figures as of October 25, 2026, from market data providers. Descriptive only, not financial advice.

GILD: Frequently asked questions

As of October 25, 2026, Gilead Sciences, Inc. has a market capitalization of $193.5 billion, making it a large-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.